Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Neurosci Lett ; 687: 124-130, 2018 11 20.
Artigo em Inglês | MEDLINE | ID: mdl-30267847

RESUMO

Stroke is the leading cause of disability and death in the world. Central post-stroke pain (CPSP), a central neuropathic pain syndrome occurring after cerebral stroke, is a serious problem. But on account of the lack of reliable animal models, the mechanisms underlying CPSP remains poorly understood. To better understand of the pathophysiological basis of CPSP, we developed and characterized a new rat model of CPSP. This model is based on a hemorrhagic stroke lesion with intra-thalamic autologous blood (ITAB) injection in the ventral posterolateral nucleus of the thalamus. Behavioral analysis demonstrated that the animals displayed a significant decrease in mechanical allodynia threshold. We found a significant increase in P2 × 4 receptor expression in microglia in thalamic peri-lesion tissues post-hemorrhage. The mechanical allodynia in rats with CPSP were reversed by blocking P2 × 4 receptors. A significant alleviation of mechanical allodynia was achieved following the administration of adrenergic antidepressants and antiepileptics. Meanwhile, we found a significant decrease in P2 × 4 receptor expression after treatment with these drugs. Taken together, our results suggest that targeting P2 × 4 receptor may be effective in the treatment of CPSP.


Assuntos
Hemorragia Cerebral/patologia , Hiperalgesia/patologia , Hemorragias Intracranianas/complicações , Receptores Purinérgicos P2X4/metabolismo , Acidente Vascular Cerebral/patologia , Animais , Modelos Animais de Doenças , Hiperalgesia/fisiopatologia , Hemorragias Intracranianas/patologia , Masculino , Microglia/patologia , Ratos Sprague-Dawley , Acidente Vascular Cerebral/fisiopatologia , Tálamo/patologia , Tálamo/fisiopatologia , Núcleos Ventrais do Tálamo/patologia , Núcleos Ventrais do Tálamo/fisiopatologia
2.
Chemosphere ; 192: 354-361, 2018 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-29121565

RESUMO

Phosphate rock in Guiyang (Southwest of China) is used for the phosphate production, and hence generating a by-product phosphogypsum (PG). From 2007, part of the PG was used as main raw material for cemented backfill. The main objective of this paper is to investigate the geochemical evolution of metals before and after the PG inclusion into the backfill matrix. A sequential extraction procedure was selected to determine the chemical speciation of metals in phosphate rock, PG, binder and field backfill samples. Dynamics of metals going from phosphate rock and PG to backfill have been evaluated. The results showed that almost all the metals in the PG and binder had been effectively transferred to the backfill. Furthermore, compared to metals taken out along with phosphate rock exploitation, PG-based cemented backfill might bring some metals back but with only little metals in mobile fraction. Additionally, in order to determine the long-term behavior of metals in PG-based cemented backfill, the field samples which were backfilled from 2007 to 2016 were collected and analyzed. The results showed that total amounts of metals in backfill were all within similar range, indicating that the cemented PG backfill could be an effective method to solidify/stabilize metals in PG. Nevertheless, Due to the high water-soluble fractions detected, the concentrations of As, Mn and Zn should be continuously monitored.


Assuntos
Sulfato de Cálcio/química , Monitoramento Ambiental/métodos , Resíduos Industriais/análise , Metais Pesados/análise , Fosfatos/isolamento & purificação , Fósforo/química , Sulfato de Cálcio/análise , China , Indústrias Extrativas e de Processamento/métodos , Mineração/métodos , Fosfatos/química , Fósforo/análise , Reciclagem/métodos
3.
Cell Physiol Biochem ; 43(2): 743-756, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28950251

RESUMO

BACKGROUND/AIMS: To evaluate the effect of Liuweibuqi capsules on chronic obstructive pulmonary disease (COPD) through the JAK/STAT pathway. METHODS: Lung function was measured with a spirometer. Changes in lung histology were observed using H&E staining. Cigarette smoke extract combined with lipopolysaccharide (CSE+LPS) was used to establish the cellular COPD model. Cytokine levels were determined using ELISA, and changes in the JAK/STAT pathway were evaluated using western blotting. The CCK8 method and flow cytometry were used to measure cell viability and apoptosis, respectively. RESULTS: Liuweibuqi capsules reduced the damage in the lung tissues and the loss of lung function in the COPD rats. Additionally, the levels of interleukin (IL)-1ß, interferon γ (IFNγ), IL-6, tumor necrosis factor (TNF)-α and transforming growth factor (TGF)-ß1 were higher, whereas IL-10 was lower in the model control (MC) and CSE+LPS groups than in the normal group. The phosphorylation levels of JAK1, JAK2, STAT1, STAT3 and STAT5 were higher and the levels of SOCS1 and SOCS3 were lower in the MC group and CSE+LPS group compared with the normal group. After Liuweibuqi capsule treatment, the expression of inflammatory cytokines and elements of the JAK/STAT pathway were lower. In addition, over-expression of STAT3 blocked the effects of the Liuweibuqi capsules on the release of inflammatory cytokines, cell viability and apoptosis. CONCLUSION: Our findings suggested that Liuweibuqi capsule might effectively ameliorate the progression of COPD via the JAK/STAT pathway.


Assuntos
Células Epiteliais Alveolares/efeitos dos fármacos , Medicamentos de Ervas Chinesas/uso terapêutico , Janus Quinases/metabolismo , Pulmão/efeitos dos fármacos , Doença Pulmonar Obstrutiva Crônica/tratamento farmacológico , Fatores de Transcrição STAT/metabolismo , Transdução de Sinais/efeitos dos fármacos , Células Epiteliais Alveolares/metabolismo , Células Epiteliais Alveolares/patologia , Animais , Células Cultivadas , Pulmão/metabolismo , Pulmão/patologia , Masculino , Doença Pulmonar Obstrutiva Crônica/metabolismo , Doença Pulmonar Obstrutiva Crônica/patologia , Ratos Sprague-Dawley
4.
Biosci Rep ; 37(5)2017 Oct 31.
Artigo em Inglês | MEDLINE | ID: mdl-28831024

RESUMO

The present study aims to investigate the effect of Liuweibuqi (LWBQ) capsules on the expression of matrix metalloproteinase (MMP)-9 and TIMP1 and cell viability of alveolar macrophages (AMs) in chronic obstructive pulmonary disease (COPD). Rats were randomly divided into normal control (NC) group, model control (MC) group, Jinshuibao (JSB) group, spleen aminopeptidase (PAT) group, and low dose of LWBQ (LWBQ low), mid dose of LWBQ (LWBQ mid), and high dose of LWBQ (LWBQ high) group (n=10). Lung function was measured with a spirometer. Serum cytokines including tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) were detected using ELISA. The expressions of MMP-9 and TIMP1 were detected by quantitative real-time PCR (qRT-PCR) and Western blot. MTT assay and flow cytometry were used to measure cell viability and apoptosis. Compared with the NC group, body weight and lung function were reduced in the MC group. In addition, the serum levels of IL-6 and TNF-α were higher in the MC group than those in the NC group. The expression of MMP-9 protein in the AMs from rats was higher, and TIMP1 protein was lower in the MC group compared with the NC group. After LWBQ capsules treatment, compared with the MC group, the expression of inflammatory cytokines and MMP-9 were lower and TIMP1 was higher. Moreover, after LWBQ-medicated serum treatment, the release of inflammatory cytokines was reduced from AMs. Besides, LWBQ-medicated serum decreased the expression of MMP-9 and increased the expression of TIMP1 and cell viability compared with those in MC group. In conclusion, LWBQ capsules can inhibit the release of inflammatory cytokines, promote cell viability in AMs, and regulate the expression of MMP-9 and TIMP1.


Assuntos
Anti-Inflamatórios/uso terapêutico , Sobrevivência Celular/efeitos dos fármacos , Medicamentos de Ervas Chinesas/uso terapêutico , Macrófagos Alveolares/efeitos dos fármacos , Metaloproteinase 9 da Matriz/análise , Doença Pulmonar Obstrutiva Crônica/tratamento farmacológico , Inibidor Tecidual de Metaloproteinase-1/análise , Animais , Anti-Inflamatórios/farmacologia , Citocinas/análise , Medicamentos de Ervas Chinesas/farmacologia , Macrófagos Alveolares/patologia , Masculino , Doença Pulmonar Obstrutiva Crônica/patologia , Ratos Sprague-Dawley
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA